In part 3 of this 4-part series, Michael Thorpy, MD, talks about advances in sodium oxybate medication formulations and how different formulations can help patients depending on their needs.
Readers can check out part 1 and part 2 now.
Various types of sodium oxybate medications provide options for patients who have sleep disorders, even those that need more or less sodium intake, says Michael Thorpy, MD, professor of neurology at the Albert Einstein College of Medicine, and director of the Sleep Disorder Center at Montefiore Medical Center.
Transcript
What monitoring and educational measures should be in place for patients prescribed sodium-based sleep medications to ensure they maintain a balanced sodium intake and follow low-sodium guidelines effectively?
There are many patients who continue to take the sodium form of sodium oxybate, and not the low-sodium formulation. These patients need to be advised about the importance of limiting any extra salt intake. There are now 3 different forms of oxybate. The standard original form of sodium oxybate is a medication that's taken twice at night. Then there's a low-sodium formulation that's also taken twice at night. But there's a new formulation of sodium oxybate, which is a once-a-night formulation.
For many patients who have had difficulty in taking the medication in the middle of the night, they prefer the sodium oxybate that's given once a night. So those patients need to be advised that although there’s a higher salt content than would be ideal, they just need to limit the amount of salt that they take extra. But so far, we don't have any actual evidence that the extra salt intake associated with sodium oxybate has caused any increase in cardiovascular concerns, which is the major concern about the extra salt, as a potential that may cause an increase in cardiovascular disorders, such as hypertension/high blood pressure.
However, patients who have cardiovascular disorders or renal disorders or problems with excessive fluid retention would be better not to take the sodium formulation and would be better on the low-sodium formulation. Patients need to be advised that there are some medical conditions that they need to be aware of that would restrict them from taking the highest sodium content.
So, education about salt intake, medical disorders that may be sensitive for salt intake are important for recommendations in guiding patients who may be taking these types of medications.
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More